Willis Towers Watson (WTW) Q1 2025 earnings summary

Executive summary

• Achieved 5% organic revenue growth in Q1 2025, despite a 5% reported revenue decline due to the TRANZACT sale; adjusted operating margin expanded by 100 basis points to 21.6%.

• Adjusted diluted EPS was $3.13, flat year-over-year, while diluted EPS rose 27% to $2.33; net income increased 23% to $239 million.

• Strategic focus on efficiency, operating leverage, portfolio optimization, and transformation savings, including the acquisition of Global Commercial Credit and progress in the reinsurance JV.

• Returned $200 million to shareholders via share repurchases and paid $88 million in dividends in Q1 2025.

• Maintains strong liquidity with $1.5 billion in cash and full access to a $1.5 billion revolving credit facility.

Financial highlights

• Q1 2025 revenue was $2.22 billion, down 5% year-over-year; organic revenue grew 5%.

• Adjusted operating margin was 21.6%, up 100 basis points; operating margin improved to 19.4% (up 740 bps).

• Adjusted diluted EPS was $3.13, up 8% year-over-year excluding TRANZACT.

• Free cash flow was negative $86 million, down $50 million year-over-year, mainly due to the TRANZACT sale and higher compensation payments.

• Net income attributable to WTW rose 23% to $239 million; adjusted EBITDA margin was 23.9%.

Outlook and guidance

• Reaffirmed full-year guidance for mid-single-digit organic growth, adjusted operating margin expansion, adjusted EPS growth, and improvement in free cash flow margin.

• Share repurchases expected to total ~$1.5 billion in 2025, subject to market and investment opportunities.

• R&B segment targeting ~100 basis points average annual margin expansion over the next 3 years; incremental margin expansion expected at HWC and enterprise levels.

• Reinsurance JV with Bain Capital expected to be a $0.25–$0.35 headwind to adjusted diluted EPS.

• Foreign currency impact on adjusted EPS expected to be neutral in 2025 at current rates.